Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Talphera Inc.

TLPH
Current price
0.89 USD -0.031 USD (-3.35%)
Last closed 0.92 USD
ISIN unknown
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 15 293 700 USD
Yield for 12 month +77.86 %
1Y
3Y
5Y
10Y
15Y
TLPH
21.11.2021 - 28.11.2021

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California. Address: 1850 Gateway Drive, San Mateo, CA, United States, 94404

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

4.17 USD

P/E ratio

Dividend Yield

Current Year

+651 000 USD

Last Year

+1 771 000 USD

Current Quarter

Last Quarter

Current Year

+340 000 USD

Last Year

-820 000 USD

Current Quarter

-1 909 000 USD

Last Quarter

-1 433 000 USD

Key Figures TLPH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -16 051 000 USD
Operating Margin TTM -4044.98 %
PE Ratio
Return On Assets TTM -47.26 %
PEG Ratio
Return On Equity TTM -118.4 %
Wall Street Target Price 4.17 USD
Revenue TTM 398 000 USD
Book Value 0.75 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.63 USD
Diluted Eps TTM -0.63 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics TLPH

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History TLPH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 26.10.2022
Dividend Date

Stock Valuation TLPH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 12.5293
Price Sales TTM 38.4264
Enterprise Value EBITDA 0.1104
Price Book MRQ 1.2014

Financials TLPH

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators TLPH

For 52 weeks

0.43 USD 1.61 USD
50 Day MA 0.93 USD
Shares Short Prior Month 42 317
200 Day MA 0.98 USD
Short Ratio 1.46
Shares Short 34 342
Short Percent 0.57 %